Place it in its market
Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.
See how Context works →On the price, the facts of the public record■Insider buy□Insider sell●Results filed
With an account, also○dividends▲splits◌next earningswith an account
End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.
Latest on record
The most recent facts, as filed.
Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.
- Aug 17, 2026Reported sale · Form 4Chrystal Jensen, Chief Legal Officer · $89.5KOpen the filing ↗
- Aug 17, 2026Notice of sale · Form 144CHRYSTAL NIKOLE JENSEN · Officer · $89.5KOpen the filing ↗
- Jul 30, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗
In numbers
What this profile holds, counted.
Closes · 1 year250
SEC filings on record1,31715 flagged findings
Reported transactions (Form 4)73since Dec 28, 2022 · and 1 other holding
Corporate events (8-K)30since Apr 1, 2019
What the record says
Description, identity and filings, each with its source.
Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.
What the company does
Cerus Corporation is an American multinational biotechnology company headquartered in Concord, California that develops and provides a treatment system to pathogen-reduce human blood products for the healthcare industry.
Source: Wikipedia (CC BY-SA 4.0) · copied on Sep 3, 2026 · may not reflect recent changes.
Regulatory history
Topics detected in its SEC reports, with the original excerpt.
Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.
- 2026-06-08capital return (buybacks/dividends)recentOpen filing ↗“…with some exclusions. The Credit Agreements contain customary affirmative covenants and customary negative covenants limiting the…”
- 2026-04-30share offering or dilution eventrecentOpen filing ↗“…through or to the Sales Agents, as sales agent or principal. Under the Amended Sales Agreement, each Sales Agent receives…”
- 2026-04-30capital return (buybacks/dividends)recentOpen filing ↗“…that the distributor will promptly and efficiently transfer its existing customer agreements to us, there can be no assurance that…”
- 2026-04-30regulatory investigationrecentOpen filing ↗“…our business practices are also subject to regulation by national, regional, state and local agencies, including but not…”
+1 more passage from the same document
- “…non-compliance; 49 • withdrawing, suspension or variation in marketing approvals or CE Certificates of Conformity that have already…”
- 2026-04-30Department of Justice inquiryrecentOpen filing ↗“…exposure to regulatory actions, substantial fines, and injunctions against processing personal information from the EEA or the…”
+1 more passage from the same document
- “…and laws governing the privacy and security of certain health information, many of which differ from each other in significant…”
Original excerpts from SEC filings, untranslated. Not advice and not a prediction.
The 25 most recent filings (of 1,317)
Every SEC filing, newest first, with what it is. Below, each type with its own explanation.
- Aug 17, 26Form 144 ↗Notice of proposed sale
- Aug 17, 26Form 4 ↗Insider transaction
- Aug 14, 26SCHEDULE 13G/A ↗Passive stake · Baker Bros. Advisors LP · 3.2% · event on Jun 30, 26 · amendment
- Aug 14, 26SCHEDULE 13G/A ↗Passive stake · ARK Investment Management LLC · 8.9% · event on Jun 30, 26 · amendment
- Aug 13, 26SCHEDULE 13G/A ↗Passive stake · Soleus Capital Master Fund, L.P. · 1.2% · event on Jun 30, 26 · amendment
- Jul 30, 2610-Q ↗Quarterly report
- Jul 30, 268-K ↗Current report · Results
- Jul 20, 26Form 4 ↗Insider transaction
- Jul 16, 26Form 144 ↗Notice of proposed sale
- Jul 10, 268-K ↗Current report · A senior executive left or was appointed
- Jun 9, 26Form 144 ↗Notice of proposed sale
- Jun 8, 268-K ↗Current report · Entered a material agreement
- Jun 3, 268-K ↗Current report · A senior executive left or was appointed
Insider transaction · 7 Form 4 filingsshow all 7hide
1,317 filings on record, the oldest from Feb 20, 97.
Listing the 25 most recent filings of the 1,317 on record.
16149
- Jul 10, 26A senior executive left or was appointed8-K 5.02 ↗
- Jun 8, 26Entered a material agreement+2 more in the same filing8-K 1.01 ↗
7 senior executive changes2025 – 2026show all 7hide
- Jun 3, 26A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Apr 21, 26A senior executive left or was appointed8-K 5.02 ↗
- Mar 16, 26A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Jan 23, 26A senior executive left or was appointed8-K 5.02 ↗
- Jun 23, 25A senior executive left or was appointed8-K 5.02 ↗
- Jun 9, 25A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Feb 6, 25A senior executive left or was appointed8-K 5.02 ↗
- Dec 9, 24Entered a material agreement8-K 1.01 ↗
- Jul 2, 24A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Jun 11, 24A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Jan 5, 24Entered a material agreement+4 more in the same filing8-K 1.01 ↗
- Apr 5, 23A material agreement was terminated+2 more in the same filing8-K 1.02 ↗
- Jul 5, 22A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- May 5, 22Entered a material agreement8-K 1.01 ↗
- Dec 23, 21Entered a material agreement+1 more in the same filing8-K 1.01 ↗
- Mar 31, 21A senior executive left or was appointed8-K 5.02 ↗
6 older filings not shown · The record reaches back to Feb 1, 05.
Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.
- Jan 29, 21Listing notice (8-K 3.01)8-K 3.01 ↗
The full record holds 1 stress filing.
Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.
Schedule 13G: short-form filing
The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.
- ARK Investment Management LLC8.9%Jun 30, 26SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 3 earlier filings
- Julian C. Baker6.8%Jun 30, 25SCHEDULE 13G/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum.
- Baker Bros. Advisors LP3.2%Jun 30, 26SCHEDULE 13G/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
- Soleus Capital Master Fund, L.P.1.2%Jun 30, 26SCHEDULE 13G/A ↗6 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.
Sale intention announced
On Aug 17, CHRYSTAL NIKOLE JENSEN filed notice of intent to sell up to $90K. That is about 0.01% of shares outstanding. It is filed under a scheduled plan (10b5-1), arranged in advance.
A notice is not a sale: it may not go ahead, may happen in part, or at a different price.
After the notice, they sold $90K on Aug 17, per their Form 4. That is 100% of the shares announced so far, and the window is still open.
View notice (Form 144) ↗+1 more recent notices · 1 with a later sale
- Aug 17, 26Sell$90KChrystal JensenChief Legal Officer↗
- Jul 16, 26Sell$53KVivek K JayaramanChief Executive Officer↗
- Jun 30, 26Sell$300KWilliam Mariner GreenmanPresident and CEO↗
- Jun 30, 26Sell$99KKevin Dennis GreenChief Financial Officer↗
- Jun 30, 26Sell$72KChrystal JensenChief Legal Officer↗
- Jun 30, 26Sell$125KVivek K JayaramanChief Operating Officer↗
- Jun 9, 26Sell$53KERIC BJERKHOLT↗
- May 29, 26Sell$50KVivek K JayaramanChief Operating Officer↗
- May 1, 26Sell$50KVivek K JayaramanChief Operating Officer↗
- Mar 12, 26Sell$169KRichard J BenjaminChief Medical Officer↗
- Mar 12, 26Sell$742KWilliam Mariner GreenmanPresident and CEO↗
- Mar 12, 26Sell$211KKevin Dennis GreenChief Financial Officer↗
There are 9 more transactions in this stretch.
Stock compensation, tax and giftsshow the 19 other transactionshide
Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.
- Jul 1, 26Compensationamount n/aVivek K JayaramanChief Operating Officer↗
- Jun 30, 26Compensationamount n/aWilliam Mariner GreenmanPresident and CEO↗
- Jun 30, 26Compensationamount n/aKevin Dennis GreenChief Financial Officer↗
- Jun 30, 26Compensationamount n/aChrystal JensenChief Legal Officer↗
- Jun 30, 26Compensationamount n/aVivek K JayaramanChief Operating Officer↗
- Jun 2, 26Compensationamount n/aHua Shan↗
- Jun 2, 26Compensationamount n/aDean A. Gregory↗
- Jun 2, 26Compensationamount n/aFrank Witney↗
- Jun 2, 26Compensationamount n/aJAMI K NACHTSHEIM↗
- Jun 2, 26Compensationamount n/aERIC BJERKHOLT↗
- Jun 2, 26Compensationamount n/aAnn Lucena↗
- Apr 1, 26Compensationamount n/aKevin Dennis GreenChief Financial Officer↗
- Apr 1, 26Compensationamount n/aChrystal JensenChief Legal Officer↗
- Mar 5, 26Compensationamount n/aRichard J BenjaminChief Medical Officer↗
- Mar 5, 26Compensationamount n/aWilliam Mariner GreenmanPresident and CEO↗
- Mar 5, 26Compensationamount n/aKevin Dennis GreenChief Financial Officer↗
- Mar 5, 26Compensationamount n/aChrystal JensenChief Legal Officer↗
- Mar 5, 26Compensationamount n/aVivek K JayaramanChief Operating Officer↗
- Mar 2, 26Compensationamount n/aRichard J BenjaminChief Medical Officer↗
The full record holds 191 transactions and goes back to Dec 28, 22.
Its sector and its market
Cerus Corporation among Health Care companies
The profile shows what is on record. Context and Radar place the company among those of its sector and region.
Browse its neighbours
Other Health Care companies
With an account you also get
- The four engines — growth, trend, risk and context — each with its word and its score.
- The risk band and the sector phase.
- The company's fundamentals and accounts.
- Watchlist: your list of companies, with the «since you follow it» figure.
The research continues
The profile tells the story. The market sets the scene.
From Cerus Corporation, the path continues in the other areas. Each one is shown with its own example, named in its step.
See what deserves a closer look
Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.
See how Radar works →Keep the why
Follow Cerus Corporation in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.
See an example review →
Coverage
What sits behind this page.
Where each figure comes from and how far it reaches.
- Prices
- End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
- Series quality
- 250 clean closes in the period.
- SEC records
- 1,317 documents on file, from Feb 20, 1997 to Aug 17, 2026.
- Company description
- Wikipedia, read on Sep 3, 2026.
- This page
- Generated on Oct 19, 2026; refreshed through the day.
Start at your own pace
Explore first. Go deeper with access.
Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.
Compare plans →- No account
This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.
- Pro
What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.
- Pro+
Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.
Are the prices real time?
No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.
Which SEC documents appear here?
Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.
Why does a European company show no SEC records?
It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.
Before forming a view on a company,
read what is on record.
One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.